Cathy Eng, Associate Director of Strategic Relations and Research Partners and Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center, shared a post on X:
“It was so wonderful to be able to participate in this ASCO session “Beyond the headlines: The Real Impact of Early-Onset Cancers”.Kimryn Rathmell, Katie Coleman, LeeAnne Bailey, Andrew Chang, NCI Cancer Trials, Mass General.”
Cathy Eng shared her involvement in an ASCO session focused on the real-world effects of early-onset cancers. The discussion featured multiple experts, highlighting diverse perspectives from institutions including NCI and Mass General.
More posts featuring Cathy Eng.